Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Israel Journal of Health Policy Research
Published in: Israel Journal of Health Policy Research 1/2019

Open Access 01-12-2019 | Integrative article

Structural effects of the information revolution on tax-funded European health systems and some potential policy responses

Author: Richard B. Saltman

Published in: Israel Journal of Health Policy Research | Issue 1/2019

Login to get access

Abstract

The ongoing information revolution has re-configured the policymaking arena for tax-funded health systems in Europe. A combination of constrained public revenues with rapid technological and clinical change has created a particularly demanding set of operational challenges. Tax-funded health systems face three ongoing struggles: 1) finding badly needed new public revenues despite inadequate GDP growth 2) channeling additional funds into new high-quality provider capacity 3) re-configuring the stasis-tied organizational structure and operations of existing public providers. This commentary reviews key elements of this new information-revolution-driven context, followed by a consideration of seven specific policy challenges that it creates and/or worsens for tax-funded European systems going forward.
Literature
1.
Engels F. The making of the English working class. Leipzig; 1845.
2.
Marx K, Engels F. The German ideology. Moscow: Marx-Engels Institute; 1932.
3.
Josephson M. The robber barons: the great American capitalists. New York: Harcourt Brace and Company; 1934.
4.
Fiorina M. Unstable majorities: polarization, Party sorting and political stalemate. Palo Alto: Hoover Press; 2017.
5.
Saltman R, Figueras J, editors. European health care reform: analysis of current strategies. Copenhagen: WHO Regional Office for Europe; 1997.
6.
Kovner A, Neuhauser D, editors. Health services management: readings and commentary. Ann Arbor: Health Administration Press, Second Edition; 1983.
7.
8.
Kingdon J. Agendas, alternatives, and public policies. 2nd ed. New York: Harper Collins College Publishers; 1995.
9.
10.
Kroneman M, Boerma W, van den Berg M, Groenewegen P, de Jong J, van Ginneken E. Netherlands: health system review. Health Syst Transit. 2016;18(2):1–240 Epub 2016/07/29. PubMed PMID: 27467715.PubMed
11.
Busse R, Blumel M. Germany: health system review. Health Syst Transit. 2014;16(2):1–296 xxi. Epub 2014/08/15. PubMed PMID: 25115137.PubMed
12.
Saltman R, Busse R, Figueras J, editors. Social health Insurance Systems in Western Europe. London: Open University Press/McGraw-Hill Education; 2004.
13.
14.
15.
Pollock AM, Shaoul J, Vickers N. Private finance and “value for money” in NHS hospitals: a policy in search of a rationale? BMJ. 2002;324(7347):1205–9 Epub 2002/05/23. PubMed PMID: 12016191; PubMed Central PMCID: PMCPMC1123165.PubMedPubMedCentralCrossRef
16.
17.
Yates J. Why are we waiting? An analysis of hospital waiting lists. Oxford: Oxford University Press; 1987.
18.
19.
20.
OECD. Health at a glance. Paris: OECD; 2012.
21.
22.
23.
Ringard A, Sagan A, Saunes I, Lindahl A. Norway: health system review, health systems in transition. European Observatory on Health Systems and Policies: Brussels; 2013.
24.
25.
Oljaz M, Nielsen A, Rudkjobing A, Birk H, Krasnik A, Hernandez-Quevedo C. Denmark: health system review. Health systems in transition. European Observatory on Health Systems and System Policies: Brussels; 2012.
26.
27.
SOU. Effectiv Vard. Stockholm: Statens Offentliga Utredningar; 2016. p. 2.
28.
SOU. Gor Det Enklare! Stockholm: Statens Offentliga Utredningar; 2012. p. 33.
29.
30.
31.
32.
33.
34.
El Erian M. World economy set to take turn towards genuine growth: Financial Times; 2018.
35.
Giles C. Weak productivity growth hampers global recovery: Financial Times; 2017.
36.
Gov.UK. Spring Statement 2018: Philip Hammond’s speech. 2018.
37.
Milne R. Market crash concerns hang over Norway’s $1 trillion oil fund: Financial Times; 2018.
38.
Jones C. Eurozone slowdown stokes concern over resilience of post-crisis recovery: Financial Times; 2018.
39.
Jones C, Pooley C. Slower German growth raises concerns for Eurozone outlook: Financial Times; 2018.
40.
Hannon P. Eurozone commercial activity slowed again in May. Wall Street J. 2018.
41.
McKee M, Karanikolos M, Belcher P, Stuckler D. Austerity: a failed experiment on the people of Europe. Clin Med (Lond). 2012;12(4):346–50 Epub 2012/08/31. PubMed PMID: 22930881.CrossRef
42.
Mladovsky P, Srivastava D, Cylus D, Karanikolos M, Evetovits E, Thomson S, et al. Health policy responses to the financial crisis in Europe. Policy summary 5. Brussels: European Observatory on Health Systems and Policies; 2012.
43.
44.
45.
Ward A. NHS to stop funding 16 cancer treatments: Financial Times; 2015.
46.
Cole A, O'Neill P, Sampson C, Lorgelly P. Barriers to uptake of minimal access surgery in the UK. London: Office of Health Economics; 2018.
47.
Smyth C. Hospitals still dangerously full as doctors warn they are exhausted: The Times; 2018.
48.
Campbell D. NHS patients waiting for hospital care top 4m for first time in a decade: Guardian; 2017.
49.
Morris J. The growing problem of treatment waiting times. Quality Watch. London: Nuffield Trust; 2018.
50.
51.
Chanturidze T. Personal communication; 2017.
52.
53.
54.
Committee on the Future of Healthcare. Slaintecare Report. Dublin: House of the Oireachtas; 2017.
55.
Kangas O, Kalliomaa-Puha L. Finland: The government’s social and healthcare reform is facing problems. European Social Policy Network Flash Report 2018/2. Brussels: European Social Observatory; 2018.
56.
Steinglass M. King’s speech to parliament heralds end of Dutch welfare state: Financial Times; 2013.
57.
58.
Gainsbury S. The bottom line: Understanding the NHS deficit and why it won’t go away: Nuffield Trust; 2017.
59.
King’s Fund. A New Settlement for Health and Social Care. London; 2014.
60.
Sylvester R. How to give the NHS extra billions it needs: The Times of London; 2018.
61.
Coates S. Tax rise needed to plug 95 billion pound black hole in NHS: The Times; 2018.
62.
Gainsbury S. NHS funding boost: the need to manage expectations: Nuffield Trust; 2018.
63.
Thomson A. The social care crisis is about more than money: The Times of London; 2018.
64.
65.
Fishing for funds. The Economist; 2018. p. 50–1.
66.
67.
68.
Coulter A. Engaging patients in healthcare. Basingstoke: Open University Press; 2011.
69.
Saltman R, Allin S, Mossialos E, Wismar M, Kutzin J. Assessing health reform trends. In: McKee M, Figueras J, editors. Health systems: health, wealth, society and well-being. Maidenhead: Open University Press/McGraw-Hill Education; 2011.
70.
71.
72.
73.
74.
Richmond C. NHS waiting list have been a boon for private medicine in the UK. CMAJ. 1996;154(3):378–81 Epub 1996/02/01. PubMed PMID: 8564909; PubMed Central PMCID: PMCPMC1487523.PubMedPubMedCentral
75.
76.
77.
Eurofound. Care homes for older Europeans: Public, for-profit and non-profit providers. Luxembourg: Publications Office of the European Union; 2017.
78.
Kettl D. Shared power. Washington: Brookings Institution; 1993.
79.
Hood C, Margetts H. The tools of government in the digital age. London: Palgrave MacMillan; 2007.CrossRef
80.
Saks M, Chamberlain J, Dent M, editors. Professional health regulation in the public interest: international perspectives. Bristol: Policy Press; 2018.
81.
Hagen T, Saltman R, Vrangbaek K. New strategies for elderly Care in Denmark and Norway. Eur Secur. 2015;21(2):23–6.
82.
83.
84.
85.
86.
Pickard J, Tetlow G. Private companies make 831 million pounds profits from NHS contracts: Financial Times; 2017.
87.
Editorial. Carillion’s failure does not vindicate Corbyn: Financial Times; 2018.
88.
Swedish Social Democratic Party. Our common approach to gain in welfare. 2014.
89.
Milne R. Swedish angst grows over tensions in public-private model: Financial Times; 2016.
90.
Pressman J, Wildavsky A. Implementation. Berkeley: University of California Press; 1973.
91.
Castle-Clarke S, Edwards N, Buckingham H. Falling short: why the NHS is still struggling to make the most of new innovations. London: Nuffield Trust; 2017.
92.
93.
94.
WHO Global Strategy on People-Centered and Integrated health Services. Service Delivery and Safety Series. Interim Report. Geneva: WHO; 2015.
95.
McKeown T. The modern rise of population. London: Edward Arnold; 1976.
96.
97.
98.
Donnelly L. NHS provokes fury with indefinite surgery ban for smokers and obese: Telegraph; 2017.
99.
Knapton S. Why British Summer Time has an unexpected impact on the NHS: Telegraph; 2018.
100.
101.
Terlep S, Mathews A, Cimilluca D. CVS to Buy Aetna for $69 Billion, Combining Major Health-Care Players: Wall Street Journal; 2017.
102.
103.
Metadata
Title
Structural effects of the information revolution on tax-funded European health systems and some potential policy responses
Author
Richard B. Saltman
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Israel Journal of Health Policy Research / Issue 1/2019
Electronic ISSN: 2045-4015
DOI
https://doi.org/10.1186/s13584-018-0284-2

Other articles of this Issue 1/2019

Israel Journal of Health Policy Research 1/2019 Go to the issue

Perspective

The Holocaust, medicine and becoming a physician: the crucial role of education

Commentary

The promise – and pitfalls – of smoke-free policy adoption

Commentary

Pharmacovigilance strategy: opportunities for cross-national learning

Original research article

Self-reported influence of monetary grants in the choice of a medical residency in remote or under-served areas

Commentary

Disparities, variations, inequalities or inequities: whatever you call them, we need data to monitor them

Commentary

Financial incentives as a governmental tool to bridge the medical manpower gap between Israel’s center and periphery